Home ExoRNA

ExoRNA

In operation
Angel Financing
miRNA Nucleic Acid Drug Developer
Basic
Enterprise Profile

Basic Information

ExoRNA Bio is a pharmaceutical company dedicated to the research and development of miRNA nucleic acid drugs, focusing on the R&D and production of nucleic acid drugs for neurological diseases, as well as anti-superbug and antiviral infectious disease nucleic acid drugs.
ExoRNA Bio
Guangdong,China
unclear
September 28, 2021
--
jingmeng.wang@exornabio.com

Enterprise Profile

Industrial Sector
New Drug Development Biological Drug Production
Technology
Nucleic Acid Technology Antibacterial/Antiviral Technology
Concept
# Brain Sciences Disease Treatment # Nervous System Diseases
Application Scenarios
Innovative Drugs Small Nucleic Acid Drugs